Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$7.51 - $10.81 $888,177 - $1.28 Million
-118,266 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$5.99 - $9.14 $21,078 - $32,163
-3,519 Reduced 2.89%
118,266 $995,000
Q2 2021

Aug 16, 2021

SELL
$7.82 - $9.3 $14,553 - $17,307
-1,861 Reduced 1.51%
121,785 $988,000
Q1 2021

May 17, 2021

BUY
$7.47 - $12.34 $79,301 - $131,001
10,616 Added 9.39%
123,646 $1.09 Million
Q4 2020

Feb 16, 2021

BUY
$9.04 - $13.01 $1.02 Million - $1.47 Million
113,030 New
113,030 $1.27 Million

Others Institutions Holding COGT

About Cogent Biosciences, Inc.


  • Ticker COGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,758,300
  • Market Cap $585M
  • Description
  • Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...
More about COGT
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.